• Trinity Delta Futura Medical Eroxon continues to build, further new launches expected

      06 February 2024


    • Trinity Delta Futura Medical Significant achievements position MED3000 for success

      18 September 2023


    • Trinity Delta Futura Medical Haleon to commercialise MED3000 in the US

      01 July 2023


    • Trinity Delta Futura Medical Key takeaways from Investor Seminar

      01 June 2023


    • Trinity Delta Futura Medical First months of Eroxon launch suggest a successful start

      01 June 2023


    • Trinity Delta Futura Medical MED3000 FDA clearance marks a major step in the US

      01 June 2023


    • Trinity Delta Futura Medical Gearing up for further launches in 2023

      01 April 2023


    • Trinity Delta Futura Medical MED3000 soft launch in Europe , FDA approval now Q2

      01 March 2023


    • Trinity Delta Futura Medical MED3000 continues to progress towards first sales

      01 December 2022


    • Trinity Delta Futura Medical On The Cusp of MED3000 Commercialisation

      01 November 2022


    • Trinity Delta Futura Medical Interims highlight positive first signs in key markets

      13 September 2022


    • Trinity Delta Futura Medical FM71 achieves all primary and secondary endpoints

      31 August 2022


    • Trinity Delta Futura Medical Major MED3000 deal for Europe with Cooper Health

      22 May 2022


    • Trinity Delta Futura Medical FY21 results reassure on cash runway and hint at EU deal

      22 April 2022


    • Trinity Delta Futura Medical Menarini to commercialise MED3000 in South Korea

      23 March 2022


    • Trinity Delta Futura Medical : A Year of delivery , with key milestones achieved

      30 September 2021


    • Trinity Delta Futura Medical Raising £12m through £10m placing and £2m retail offer

      17 May 2021


    • Trinity Delta Futura Medical MED3000 receives CE Mark as a Class II(b) device

      30 April 2021


    • Trinity Delta Futura Medical FY21 is set to be a year of execution

      14 April 2021


    • Trinity Delta Futura Medical EU Notified Body recommends MED3000 approval

      19 March 2021


    • Trinity Delta Futura Medical Commercialisation deal for China and SE Asia

      04 March 2021


    • Trinity Delta Futura Medical Lighthouse

      22 October 2020


    • Trinity Delta Futura Medical MED3000 on course for OTC approval in Europe and US

      16 September 2020


    • Trinity Delta FDA green lights MED3000 for OTC approval

      14 July 2020


    • Trinity Delta Futura Medical Outlook

      02 June 2020


    • Trinity Delta details more on FM57 Results

      02 April 2020


    • Trinity Delta details FY19 results and MED3000 update

      01 April 2020


    • Trinity Delta details of the MED3000 European regulatory pathway

      17 February 2020


    • Trinity Delta Initiates Coverage

      25 November 2019